← All organizations
Highest phase reached
Phase 4
First clinical trial
Apr 1, 2005Last known activity
Sep 30, 2025
Timeline
1950s
- Jan 1, 1954
Handok Pharmaceuticals Co., Ltd.— Founded
Drugs by trial phase (27 distinct, 43 trials)
Phase 4 (11 own, 0 via acquisition)
Phase 3 (6 own, 0 via acquisition)
Phase 2 (4 own, 0 via acquisition)
Phase 1 (5 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Studied for
- Cryopyrin-Associated Periodic Syndromes
- Diabetes Mellitus
- Diabetes Mellitus, Type 2
- Digestive System Neoplasms
- Essential Hypertension
- Gastrointestinal Neoplasms
- Hyperplasia
- Hypertension
- Neoplasms
- Osteoarthritis
- Prostatic Hyperplasia
- Pruritus
- Psychotic Disorders
- Rhinitis
- Rhinitis, Allergic
- Schizophrenia
- Skin Diseases
- Syndrome
- Urinary Bladder Neoplasms
Recent trials (48)
- NCT07102719Lead sponsorPhase 1Sep 30, 2025
- NCT06889350Lead sponsorPhase 1Mar 26, 2025
- NCT06339788Lead sponsorPhase 1Apr 30, 2024
- NCT05504226Lead sponsorPhase 3Oct 31, 2022
- NCT05504239Lead sponsorPhase 3Oct 31, 2022
- NCT05688085Lead sponsorPhase 1Oct 18, 2022
- NCT05688098Lead sponsorPhase 1Sep 23, 2022
- NCT05663073Lead sponsorPhase 1Sep 13, 2022
- NCT05476354Lead sponsorPhase 3Aug 31, 2022
- NCT05475665Lead sponsorPhase 3Jul 14, 2022
- NCT04431141Lead sponsorPhase 1Jul 31, 2020
- NCT04492033Lead sponsorPhase 1/Phase 2Jun 22, 2020
- NCT04488978Lead sponsorPhase 2May 21, 2020
- NCT04421911Lead sponsorPhase 3Apr 6, 2020
- NCT04014257CollaboratorPhase 1Jul 25, 2019
Details
- Founded
- Seoul, KR Jan 1, 1954
- Last known activity
- Sep 30, 2025